AC Chiang, H Asghari, K Ashley, S Gettinger, S Goldberg, R Herbst, FH Wilson, BR Newton, MK Cohenuram, KD Sabbath, AS Talsania, AV Russo, E Schultz, S Skrzypczak, C Kingsford, and KS Schalper (2023) Molecular predictors and immunomodulatory role of dual checkpoint inhibitor blockade using ipilimumab/nivolumab in patients with extensive stage small cell lung cancer. J Clin Oncol 41, 2023 (suppl 16; abstr 8597).
DOI | Paper
View source